CA
FLGT icon

Cliff Asness’s Fulgent Genetics FLGT Stock Holding History

Cliff Asness’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Buy
69,453
+40,009
+136% +$678K ﹤0.01% 2817
2026
Q1 		$468K Buy
+29,444
New +$639K ﹤0.01% 3156
2023
Q2 		– Sell
-112,949
Closed -$3.53M – 2217
2023
Q1 		$3.53M Sell
112,949
-48,502
-30% -$1.56M 0.01% 1040
2022
Q4 		$4.81M Buy
161,451
+65,682
+69% +$2.35M 0.01% 910
2022
Q3 		$3.65M Buy
95,769
+56,562
+144% +$2.84M 0.01% 951
2022
Q2 		$2.14M Buy
39,207
+4,824
+14% +$265K ﹤0.01% 1071
2022
Q1 		$2.15M Buy
34,383
+19,385
+129% +$1.28M ﹤0.01% 1137
2021
Q4 		$1.51M Buy
14,998
+2,916
+24% +$256K ﹤0.01% 1344
2021
Q3 		$1.09M Sell
12,082
-1,241
-9% -$113K ﹤0.01% 1490
2021
Q2 		$1.23M Buy
13,323
+6,444
+94% +$515K ﹤0.01% 1490
2021
Q1 		$665K Sell
6,879
-3,222
-32% -$333K ﹤0.01% 1727
2020
Q4 		$526K Sell
10,101
-3,894
-28% -$163K ﹤0.01% 1757
2020
Q3 		$560K Buy
+13,995
New +$438K ﹤0.01% 1672

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cliff Asness's FLGT Position: Q2 2026 in Review

Cliff Asness increased its Fulgent Genetics (FLGT) stake by 136% in Q2 2026, buying an estimated $678K and bringing the position to 69,453 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2817.

Cliff Asness first reported a position in FLGT in Q3 2020 and has held it in 13 quarters since. The position peaked at $4.81M in Q4 2022. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Cliff Asness held 69,453 shares of Fulgent Genetics worth $1.43M as of Q2 2026.
  • Cliff Asness bought 40,009 Fulgent Genetics shares in Q2 2026, an estimated $678K.
  • Fulgent Genetics made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2817 holding.
  • Cliff Asness first reported a position in Fulgent Genetics in Q3 2020 and has held it in 13 quarters since.
  • Cliff Asness's Fulgent Genetics position peaked at $4.81M in Q4 2022.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.